Qatar Biomedical Research Institute QBRI

Overview

The Translational Cancer and Immunity Center (TCIC) aims to achieve a better understanding of the cellular and molecular bases of cancer initiation and progression with a focus on breast cancer, which is the most common type of cancer among females globally.

The TCIC’s highest priority is to shed more light on cancer issues that impact Qatar and the Arab region, areas of the world that are underrepresented in cancer research.

A new relevant and contemporary direction for the center is to conduct research in the area of infectious diseases and immunity.

Research Areas

This area explores the tumor microenvironment to gain insight into some of the mechanisms utilized by tumor cells to evade immune-mediated destruction, and how these can be used to develop novel immune-based interventions. The Cancer Immunology and Immunotherapy theme has a vested interest in the development of immunotherapeutic approaches using genetically modified immune cells. Dr. Julie Decock and Dr. Mariam Al-Muftah

This area focuses its research efforts on the identification of diagnostic, prognostic, predictive biomarkers, and novel therapeutic targets for breast cancer. CRC investigators are exploring the potential utilization of protein coding (mRNA), noncoding RNAs (lncRNAs and miRNAs), proteins, and metabolites in breast cancer tissue and circulation as potential disease biomarkers and targets for therapeutic interventions. Dr. Nehad AlAjez and Dr. Fares Al Ejeh